CervoMed CRVO
NASDAQ CRVO
$2.88 +0.21 (+7.87%)
At close: Sep 29, 2026 · 4:00 PM EDT

CervoMed (CRVO) Share-based Compensation (2010 - 2026)

Updated

CervoMed (CRVO) reported Share-based Compensation of $362,275 for Q2 2026, down 27.1% from $497,015 a year earlier but up 3.7% from the prior quarter.

Analysis

CervoMed (CRVO) Share-based Compensation (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, CervoMed's Share-based Compensation came in at $1.3 million, down 11.3% year-over-year; for FY2025, it was $1.45 million, up 3.1% from FY2024.

  • Share-based Compensation has increased for three consecutive years, with a five-year compound annual growth rate of 14.5% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $1.41 million in FY2024 (+244.9%), $407,632 in FY2023 (+22.1%), $333,835 in FY2022 (-62.8%) and $897,260 in FY2021 (+21.9%).
  • Five-year quarterly Share-based Compensation spans a low of -$303,414 in Q3 2022 and a high of $578,581 in Q2 2024.
  • Year over year, Share-based Compensation has now declined in each of the last three quarters, with growth averaging 33.8% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was Q2 2024 (growth of 829.4%); the low point was Q2 2023 (a decline of 77.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $349,196 (Q1 2026), $298,735 (Q4 2025) and $291,717 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 CervoMed 27.35 Mn 27.35 Mn - 362,275.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 362,275.00
Mar 31, 2026 349,196.00
Dec 31, 2025 298,735.00
Sep 30, 2025 291,717.00
Jun 30, 2025 497,015.00
Mar 31, 2025 361,167.00
Dec 31, 2024 337,711.00
Sep 30, 2024 271,215.00
Jun 30, 2024 578,581.00
Mar 31, 2024 218,215.00
Dec 31, 2023 164,972.00
Sep 30, 2023 109,168.00
Jun 30, 2023 62,252.00
Mar 31, 2023 71,240.00
Dec 31, 2022 80,988.00
Sep 30, 2022 -303,414.00
Jun 30, 2022 278,130.00
Mar 31, 2022 278,131.00
Dec 31, 2021 254,308.00
Sep 30, 2021 164,392.00
API Access

CervoMed Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CRVO&period=max&api_key=YOUR_API_KEY